5-1280216-C-T

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong

The NM_198253.3(TERT):​c.1892G>A​(p.Arg631Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R631W) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 34)

Consequence

TERT
NM_198253.3 missense

Scores

10
7
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:11O:1

Conservation

PhyloP100: 4.14

Publications

18 publications found
Variant links:
Genes affected
TERT (HGNC:11730): (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
TERT Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dyskeratosis congenita, autosomal dominant 2
    Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • dyskeratosis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hoyeraal-Hreidarsson syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • melanoma, cutaneous malignant, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr5-1280217-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 916675.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.994
PP5
Variant 5-1280216-C-T is Pathogenic according to our data. Variant chr5-1280216-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 29899.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TERTNM_198253.3 linkc.1892G>A p.Arg631Gln missense_variant Exon 4 of 16 ENST00000310581.10 NP_937983.2 O14746-1
TERTNM_001193376.3 linkc.1892G>A p.Arg631Gln missense_variant Exon 4 of 15 NP_001180305.1 O14746-3
TERTNR_149162.3 linkn.1971G>A non_coding_transcript_exon_variant Exon 4 of 13
TERTNR_149163.3 linkn.1971G>A non_coding_transcript_exon_variant Exon 4 of 13

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TERTENST00000310581.10 linkc.1892G>A p.Arg631Gln missense_variant Exon 4 of 16 1 NM_198253.3 ENSP00000309572.5 O14746-1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dyskeratosis congenita, autosomal dominant 2 Pathogenic:3
May 20, 2023
Neuberg Centre For Genomic Medicine, NCGM
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The missense variant c.1892G>A(p.Arg631Gln) in TERT gene has been observed in heterozygous and/or compound heterozygous state in individual(s) with clinical features of TERT-related conditions (Collopy LC et. al.,; 2015; Norberg A et. al., 2018). It has also been observed to segregate with disease in related individuals. Experimental studies have shown that this missense change affects TERT function (Collopy LC et. al.,; 2015). The observed variant is absent in gnomAD exomes database. This variant has been reported to the ClinVar database as Pathogenic by multiple submitters. Multiple lines of computational evidence (Polyphen - probably damaging, SIFT - damaging and MutationTaster - disease causing) predict a damaging effect on protein structure and function for this variant. The reference amino acid change p.Arg631Gln in TERT is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 631 is changed to a Gln changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. -

Jun 01, 2008
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jun 08, 2023
3billion
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.91; 3Cnet: 0.98). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000029899 /PMID: 18460650). A different missense change at the same codon (p.Arg631Trp) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000916675 /PMID: 26859482). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -

not provided Pathogenic:2
May 04, 2022
Genetic Services Laboratory, University of Chicago
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

DNA sequence analysis of the TERT gene demonstrated a sequence change, c.1892G>A, in exon 4 that results in an amino acid change, p.Arg631Gln. The p.Arg631Gln change affects a highly conserved amino acid residue located in a domain of the TERT protein that is known to be functional. The p.Arg631Gln substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Experimental studies have demonstrated that this sequence change impacts the function of the TERT protein (PMID: 26024875, 19760749). This sequence change has previously been described in multiple individuals with TERT-related disorders (PMID: 29920840, 22853774, 19760749, 18460650, 26024875, 29483670). This sequence change has not been described in population databases such as ExAC and gnomAD. The p.Arg631Gln amino acid change occurs in a region of the TERT gene where other missense sequence changes have been described in individuals with TERT-related disorders including another missense change at the same position (p. Arg631Trp) (PMID: 26859482, 26329388, 30523342). Collectively, these evidences indicate this sequence change is pathogenic. -

Feb 08, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate a damaging effect: decreased TERT protein expression and negligible telomerase activity with correspondingly short telomeres (PMID: 26024875, 20502709, 19760749); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20301779, 20502709, 19760749, 18460650, 26024875, 22853774, 23716176, 29483670, 18302718) -

Interstitial lung disease 2 Pathogenic:1Other:1
May 06, 2018
Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:case-control

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Pathogenic:1
Dec 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 631 of the TERT protein (p.Arg631Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of TERT-related conditions (PMID: 18460650, 19760749, 22853774, 26024875, 29483670). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 29899). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt TERT protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects TERT function (PMID: 19760749, 26024875). For these reasons, this variant has been classified as Pathogenic. -

Telomere syndrome Pathogenic:1
Aug 01, 2022
The Telomere Center at Johns Hopkins, Johns Hopkins University School of Medicine
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Pulmonary fibrosis Pathogenic:1
Jun 09, 2022
Garcia Pulmonary Genetics Research Laboratory, Columbia University Irving Medical Center
Significance:Likely risk allele
Review Status:no assertion criteria provided
Collection Method:research

Leukocyte telomere length (by qPCR) less than 10th percentile age-adjusted -

Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 Pathogenic:1
Nov 23, 2017
Degerman lab, Umeå University
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dyskeratosis congenita Pathogenic:1
Nov 10, 2022
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R631Q pathogenic mutation (also known as c.1892G>A), located in coding exon 4 of the TERT gene, results from a G to A substitution at nucleotide position 1892. The arginine at codon 631 is replaced by glutamine, an amino acid with highly similar properties. This mutation has been reported in multiple families with idiopathic pulmonary fibrosis or dyskeratosis congenita (Basel-Vanagaite L, et al. Haematologica. 2008 Jun; 93(6):943-4; Kirwan M, et al. Br. J. Haematol. 2008 Mar; 140(6):719-22; Kirwan M, et al. Hum. Mutat. 2009 Nov; 30(11):1567-73; Diaz de Leon A, et al. PLoS ONE. 2010 May; 5(5):e10680; Fernandez BA, et al. Respir. Res. 2012 ; 13():64; Collopy LC, et al. Blood. 2015 Jul; 126(2):176-84). Functional analysis in several studies demonstrated that this mutation severely reduced telomerase activity (Kirwan M, et al. Hum. Mutat. 2009 Nov; 30(11):1567-73;Diaz de Leon A, et al. PLoS ONE. 2010 May; 5(5):e10680; Collopy LC, et al. Blood. 2015 Jul; 126(2):176-84). In addition, this variant was shown to segregate with disease in a family in which the proband was shown to have short telomere length relative to controls (Norberg A et al. Eur. J. Hum. Genet., 2018 06;26:858-867). Based on the supporting evidence, p.R631Q is interpreted as a disease-causing mutation. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.75
BayesDel_addAF
Pathogenic
0.53
D
BayesDel_noAF
Pathogenic
0.53
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.94
D;.
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Pathogenic
0.92
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.2
M;M
PhyloP100
4.1
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-3.5
D;D
REVEL
Pathogenic
0.91
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.0060
D;D
Polyphen
1.0
D;D
Vest4
0.92
MutPred
0.92
Loss of MoRF binding (P = 0.0317);Loss of MoRF binding (P = 0.0317);
MVP
1.0
MPC
2.3
ClinPred
0.99
D
GERP RS
4.5
Varity_R
0.76
gMVP
1.0
Mutation Taster
=1/99
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199422294; hg19: chr5-1280331; API